Using postoperative SNOT-22 to help predict the probability of revision sinus surgery

Rudmik, Luke; Soler, Zachary M.; Hopkins, Claire

doi:10.4193/rhin15.284

Cited by 28 publications

(23 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…50 Also the balance between repetitive surgery, especially in patients with CRSwNP, and the side-effect of intensified medical treatment should be discussed. 51 • Participation of the patient in the therapeutic plan, with clear information on the goals and practical implications of different therapeutic strategies on the short and long term, including postoperative care, importance of compliance to treatment regimes and avoidance of irritants.…”

Section: Integrated Care Pathways (Icps)mentioning

confidence: 99%

Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

Hellings

Fokkens

Bachert

et al. 2017

Allergy

161

154

View full text Add to dashboard Cite

Precision medicine (PM) is increasingly recognized as the way forward for optimizing patient care. Introduced in the field of oncology, it is now considered of major interest in other medical domains like allergy and chronic airway diseases, which face an urgent need to improve the level of disease control, enhance patient satisfaction and increase effectiveness of preventive interventions. The combination of personalized care, prediction of treatment success, prevention of disease and patient participation in the elaboration of the treatment plan is expected to substantially improve the therapeutic approach for individuals suffering from chronic disabling conditions. Given the emerging data on the impact of patient stratification on treatment outcomes, European and American regulatory bodies support the principles of PM and its potential advantage over current treatment strategies. The aim of the current document was to propose a consensus on the position and gradual implementation of the principles of PM within existing adult treatment algorithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS). At the time of diagnosis, prediction of success of the initiated treatment and patient participation in the decision of the treatment plan can be implemented. The second‐level approach ideally involves strategies to prevent progression of disease, in addition to prediction of success of therapy, and patient participation in the long‐term therapeutic strategy. Endotype‐driven treatment is part of a personalized approach and should be positioned at the tertiary level of care, given the efforts needed for its implementation and the high cost of molecular diagnosis and biological treatment.

show abstract

Section: Integrated Care Pathways (Icps)mentioning

confidence: 99%

Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

Hellings

Fokkens

Bachert

et al. 2017

Allergy

161

154

View full text Add to dashboard Cite

show abstract

“…Incomplete initial surgery or lack of compliance to prescribed, long‐term medical therapy may be other reasons . Numerous single‐institution studies have been performed to identify factors impacting CRSwNP revision rates, but reporting has varied significantly . Further study is needed to gain an understanding of the broader applicability of these findings to clinical management .…”

mentioning

confidence: 99%

“…3,7 Numerous single-institution studies have been performed to identify factors impacting CRSwNP revision rates, but reporting has varied significantly. 8,9 Further study is needed to gain an understanding of the broader applicability of these findings to clinical management. 10,11 The purpose of this study was to systematically examine published revision rates for CRSwNP, as well as identify factors associated with higher revision rates.…”

mentioning

confidence: 99%

Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta‐analysis of risk factors

Loftus

Soler

Koochakzadeh

et al. 2019

Int Forum Allergy Rhinol

137

140

View full text Add to dashboard Cite

Background Wide variations in revision endoscopic sinus surgery (ESS) rates for chronic rhinosinusitis with nasal polyposis (CRSwNP) have been reported. It is important to understand expected revision rates and factors that impact the need for revision. Methods A literature search was conducted on PubMed, Scopus, and the Cochrane Database of Systematic Reviews. Following PRISMA guidelines, a systematic review and meta‐analysis was performed on studies that reported revision surgery data for CRSwNP patients. Results Forty‐five studies with 34,220 subjects were meta‐analyzed, with an overall revision rate of 18.6% (95% confidence interval, 14.1%‐23.6%). Studies with extractable follow‐up data reported a mean revision rate of 16.2% over a weighted mean follow‐up of 89.6 months. Factors associated with increased revision rates included allergic fungal rhinosinusitis (28.7%), aspirin‐exacerbated respiratory disease (27.2%), asthma (22.6%), prior polypectomy (26.0%), and publication prior to 2008 (22.7%) (p < 0.05 for all). Conclusion Although polyps can recur after ESS, reported long‐term ESS revision rates are approximately 14% to 24%. Identifying risk factors for revision surgery can help manage patient expectations and determine optimal personalized treatments.

show abstract

“…Early surgical intervention after a trial of medical therapy may also deliver better symptomatic outcomes that are sustained for as long as five years (67) . least some abnormalities at CT scan (68) . Pre-and post-operative measures of patient rated outcome scores such as the Sinonasal Outcome Test-22 may be used to predict benefit from surgery and identify early failure (69,70) .…”

Section: Optimising the Outcome Of Surgical Intervention I) Timing Ofmentioning

confidence: 99%

Prevention of chronic rhinosinusitis

Hopkins

Šurda

Bast

et al. 2018

Rhin

Self Cite

View full text Add to dashboard Cite

Using postoperative SNOT-22 to help predict the probability of revision sinus surgery

Abstract: Outcomes from this study suggest that identifying MCID changes in the SNOT-22 score within 12 months after primary ESS can identify patients at increased risk for needing revision surgery.

Cited by 28 publications

References 8 publications

Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta‐analysis of risk factors

Prevention of chronic rhinosinusitis

Contact Info

Product

Resources

About